Breaking News, Collaborations & Alliances

Resolution Therapeutics and CCRM Enter Research Collaboration

Will develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Resolution Therapeutics Limited, a biopharmaceutical company developing macrophage cell therapies to treat advanced liver disease, CCRM, a company developing and commercializing regenerative medicine-based technologies and cell and gene therapies, and OmniaBio Inc., CCRM’s subsidiary, have announced a research collaboration to develop and scale up a manufacturing platform for Resolution’s off-the-shelf iPSC-derived macrophage cell therapies.   “An off-the-shelf product offering will reduce the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters